Bob Nellis (@bobnellis)
Activity by Bob Nellis
The title is the key message of Mark Frye, M.D,, head of Mayo Clinic's department of psychiatry and psychology today to a group of 20 top medical journalists in Rochester, MN. Just in this morning from the national psychiatry conference in Toronto, Dr. Frye told fellows from the National Press Club Foundation how precision medicine testing can alert physicians as to the appropriate medication for someone with bipolar disorder and also serve as a diagnostic tool. He also outline how Mayo's Bipolar Biobank is helping in research on new treatments for bipolar disorder.
He told the reporters that a person who has one bipolar manic episode has a 90 percent chance of having another, and [...]
A second-year student at Mayo Medical School -- Soyun (S. Michelle) Hwang -- has been selected by the Howard Hughes Medical Institute (HHMI) to receive a year-long fellowship to conduct mentored biomedical research. Hwang will be mentoring at Mayo Clinic with Jennifer Westendorf, Ph.D., in orthopedic surgery. She will purse her interest in reconstructive surgery, which overlaps with surgical fields like orthopedics. She met Dr. Westendorf at the Perry Initiative, a national event aimed at diversifying the field of orthopedics.
“This is a phenomenal opportunity,” Hwang says. “I conducted proteomics research for 5 to 6 years in muscle diseases prior to coming to Mayo and I have always regarded research as one [...]
A team of Mayo Clinic ophthalmologists have validated what they are calling a user-friendly computer program for pediatric vision testing. Tomohiko Yamada, O.D. and colleagues tested the the Jaeb Visual Acuity Screener (JVAS) - a computerized test -- on 175 children between 3 and 7 years old. After that, they were also tested by an expert ophthalmologist using conventional methods. The screening test is fast -- an average of only 84 seconds to obtain the crucial information. It's also fairly accurate. Compared to the physician exam, the computer test had only 9 to 17 percent falls positives, depending on the screen criteria. And it uses an algorithm that helps prevent tester bias.
Why is something like [...]
Richard Joseph, M.D., an oncologist specializing in melanoma at Mayo Clinic’s Florida campus, has been named the 2015 recipient of the “Doctor of the Year Award” presented by the Melanoma International Foundation (MIF). Founded in 2003, MIF is a non-profit organization whose vision is a future where top-notch melanoma treatment is accessible to all patients globally. Now in its tenth year, the annual award not only recognizes a physician involved in clinical research that is on the cutting edge of melanoma treatment, but who also exhibits a caring attitude towards his/her patients.
Dr. Joseph is actively involved in multiple leading edge clinical [...]
A research group led by Mayo Clinic neuroscientist Eugenia Trushina, Ph.D, has investigated whether treatment with a small molecule CP2 can prevent the debilitating effects of Alzheimer’s disease in three animal models of familial Alzheimer's, an inherited neurodegenerative disorder with symptoms of progressive cognitive decline in aging populations.
There is no cure for Alzheimer's in humans, and with no treatment aimed to prevent or stem the disease, it is estimated that 100 million people might suffer from Alzheimer's by 2050.
Dr. Trushina and her colleagues have shown that, by mildly inhibiting mitochondrial complex I with CP2, they reduce the levels of the biomarkers amyloid [...]
Mayo Clinic's Center for Individualized Medicine -- with the University of Illinois at Urbana-Champaign and the University of Chicago -- is establishing a National Science Foundation Industry/University Collaborative Research Center called the Center for Computational Biotechnology and Genomic Medicine, or CCBGM. The goal is to study the applicability, timeliness, efficiency, and accuracy of the computational infrastructure that will address pressing genome-based challenges, through collaborative projects that include two or more of the member institutions. A key element of this NSF funding model is to recruit industry partners into the Center as a way to fund the research. The CCBGM recently hosted a planning meeting for university staff and representatives from 27 companies in primarily the biotech and computer [...]
In 1983, when Moses Rodriguez, M.D., established a small research lab to study multiple sclerosis (MS) at Mayo Clinic, he was told that he was wasting his time.
Dr. Rodriguez, now an emeritus staff member, was trained as a physician in neurology. Adding basic science research to his portfolio would be impossible, he was told.
But Dr. Rodriguez wanted very much to be both a physician and researcher. As a physician he would specialize in identifying and treating neurologic problems, but then as a researcher, he would take those problems back to the lab where he would begin looking for solutions. Dr. Rodriguez has spent [...]
Mayo Clinic physician and researcher Edith A. Perez, M.D. has been named to the Board of Directors of the American Association for Cancer Research. She is among five new members elected to serve on the AACR board for the 2015-2018 term and four members to serve on the nominating committee for the 2015-2017 term. They will begin their terms at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22. Dr. Perez is an internationally regarded breast cancer specialist and scientist based at Mayo Clinic's campus in Florida.
She is deputy director at large at the Mayo [...]